Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 00:00 | 2025-03-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $928.76 | 220,000 | $204,326,144 | 96,016,978 | -0.2% |
| 2025-02-27 00:00 | 2025-02-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $903.07 | 225,000 | $203,190,795 | 96,236,978 | -0.2% |
| 2025-02-26 00:00 | 2025-02-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $27,282.83 | 60,432 | $1,648,756,037 | 96,461,978 | -0.1% |
| 2025-02-25 00:00 | 2025-02-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $882.70 | 99,452 | $87,786,509 | 96,522,410 | -0.1% |
| 2025-02-22 00:00 | 2025-02-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $877.99 | 14,685 | $12,893,352 | 96,621,862 | 0.0% |
| 2025-02-21 00:00 | 2025-02-19 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $878.45 | 9,985 | $8,771,285 | 96,636,547 | 0.0% |
| 2025-02-15 00:00 | 2025-02-13 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $879.52 | 35,446 | $31,175,395 | 96,646,532 | 0.0% |
| 2025-02-13 00:15 | 2025-02-10 | LLY | ELI LILLY & Co | Skovronsky Daniel | Officer; EVP, CSO & Pres. LRL & LLY Imm | Pharmaceutical Preparations | SALE | $863.21 | 5,000 | $4,316,065 | 117,888 | -4.1% |
| 2025-02-08 00:00 | 2025-02-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $874.13 | 210,000 | $183,567,258 | 96,681,978 | -0.2% |
| 2024-11-09 00:18 | 2024-11-08 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $803.38 | 900 | $723,042 | 5,480 | -14.1% |
| 2024-09-04 23:05 | 2024-09-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $966.69 | 24,084 | $23,281,839 | 96,891,978 | 0.0% |
| 2024-08-28 23:05 | 2024-08-27 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $968.46 | 24,552 | $23,777,667 | 96,916,062 | 0.0% |
| 2024-08-26 23:21 | 2024-08-26 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $950.00 | 750 | $712,500 | 6,380 | -10.5% |
| 2024-08-23 23:05 | 2024-08-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $966.33 | 3,196 | $3,088,382 | 96,940,614 | 0.0% |
| 2024-07-11 23:00 | 2024-07-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $939.82 | 210,000 | $197,361,402 | 96,943,810 | -0.2% |
| 2024-07-09 23:00 | 2024-07-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $918.64 | 93,593 | $85,977,955 | 97,153,810 | -0.1% |
| 2024-07-08 23:00 | 2024-07-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $915.18 | 52,369 | $47,927,192 | 97,247,403 | -0.1% |
| 2024-07-03 23:00 | 2024-07-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $915.31 | 8,848 | $8,098,655 | 97,299,772 | 0.0% |
| 2024-07-02 23:00 | 2024-07-01 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $915.26 | 58,749 | $53,770,774 | 97,308,620 | -0.1% |
| 2024-07-01 23:00 | 2024-06-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $915.02 | 1,441 | $1,318,545 | 97,367,369 | 0.0% |
| 2024-06-26 23:00 | 2024-06-25 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $903.82 | 188,100 | $170,009,257 | 97,368,810 | -0.2% |
| 2024-06-25 23:00 | 2024-06-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $902.38 | 17,229 | $15,547,069 | 97,556,910 | 0.0% |
| 2024-06-21 23:00 | 2024-06-20 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $902.67 | 9,671 | $8,729,733 | 97,574,139 | 0.0% |
| 2024-06-18 23:00 | 2024-06-17 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $885.91 | 194,978 | $172,733,701 | 97,583,810 | -0.2% |
| 2024-06-17 23:00 | 2024-06-14 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $882.47 | 15,022 | $13,256,490 | 97,778,788 | 0.0% |
| 2024-06-11 23:00 | 2024-06-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $860.78 | 75,510 | $64,997,271 | 97,793,810 | -0.1% |
| 2024-06-10 23:00 | 2024-06-07 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $852.29 | 139,490 | $118,886,588 | 97,869,320 | -0.1% |
| 2024-06-07 23:00 | 2024-06-06 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $837.82 | 179,617 | $150,485,871 | 98,008,810 | -0.2% |
| 2024-06-06 23:00 | 2024-06-05 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $836.32 | 20,383 | $17,046,672 | 98,188,427 | 0.0% |
| 2024-06-04 23:00 | 2024-06-03 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $829.77 | 192,794 | $159,974,041 | 98,208,810 | -0.2% |
| 2024-06-03 23:00 | 2024-05-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $822.11 | 22,206 | $18,255,870 | 98,401,604 | 0.0% |
| 2024-06-03 23:14 | 2024-06-03 | LLY | ELI LILLY & Co | Norton Johna | Officer; EVP, Global Quality | Pharmaceutical Preparations | SALE | $819.38 | 7,056 | $5,781,545 | 25,428 | -21.7% |
| 2024-06-03 23:15 | 2024-06-03 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $819.47 | 750 | $614,603 | 7,130 | -9.5% |
| 2024-05-30 23:00 | 2024-05-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $811.04 | 130,385 | $105,747,972 | 98,423,810 | -0.1% |
| 2024-05-29 23:00 | 2024-05-28 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $809.00 | 2,052 | $1,660,068 | 98,554,195 | 0.0% |
| 2024-05-28 23:00 | 2024-05-24 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $809.21 | 92,563 | $74,902,998 | 98,556,247 | -0.1% |
| 2024-05-24 23:00 | 2024-05-23 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $809.99 | 50,767 | $41,120,960 | 98,648,810 | -0.1% |
| 2024-05-23 23:00 | 2024-05-22 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $804.18 | 12,974 | $10,433,483 | 98,699,577 | 0.0% |
| 2024-05-22 23:00 | 2024-05-21 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $805.45 | 186,259 | $150,021,697 | 98,712,551 | -0.2% |
| 2024-03-11 23:27 | 2024-03-11 | LLY | ELI LILLY & Co | Zakrowski Donald A | Officer; SVP, Finance, & CAO | Pharmaceutical Preparations | SALE | $753.60 | 750 | $565,200 | 7,880 | -8.7% |
| 2024-02-21 00:05 | 2024-02-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $780.99 | 169,684 | $132,521,931 | 98,898,810 | -0.2% |
| 2024-02-17 00:05 | 2024-02-15 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $760.46 | 50,316 | $38,263,416 | 99,068,494 | -0.1% |
| 2024-02-13 00:05 | 2024-02-09 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $740.60 | 206,257 | $152,753,419 | 99,118,810 | -0.2% |
| 2024-02-10 00:05 | 2024-02-08 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $740.06 | 8,743 | $6,470,336 | 99,325,067 | 0.0% |
| 2024-02-02 00:00 | 2024-01-31 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $648.07 | 78,573 | $50,920,922 | 99,333,810 | -0.1% |
| 2024-02-01 00:05 | 2024-01-30 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $645.22 | 76,215 | $49,175,198 | 99,412,383 | -0.1% |
| 2024-01-31 00:05 | 2024-01-29 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $645.07 | 54,032 | $34,854,422 | 99,488,598 | -0.1% |
| 2024-01-18 00:05 | 2024-01-16 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $645.60 | 1,180 | $761,806 | 99,542,630 | 0.0% |
| 2024-01-13 00:05 | 2024-01-11 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $634.13 | 12,344 | $7,827,686 | 99,543,810 | 0.0% |
| 2024-01-12 00:05 | 2024-01-10 | LLY | ELI LILLY & Co | LILLY ENDOWMENT INC | 10% owner | Pharmaceutical Preparations | SALE | $630.59 | 163,730 | $103,246,370 | 99,556,154 | -0.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.